drugset / Trial / NCT06769984
A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.
RandomizedParallel-groupDouble-blindTreatment
Summary
Multicentre, Randomized, Double-blinded, Phase I/II Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease
Timeline
- Start
- 2025-02-19
- Primary completion
- 2026-06-24
- Completion
- 2028-09-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SCTT11 | Unknown | — | — |
Indications
No indication recorded.